A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report

被引：0

作者：

Merhaben, Salma ^{[1
]}

Ayadi, Shema ^{[1
]}

Tangour, Monia ^{[2
]}

Boujelbene, Nadia ^{[2
]}

Ghariani, Rayfa ^{[3
]}

Mouelhi, Leila ^{[1
]}

Merhaben, Fathi ^{[4
]}

机构：

[1] Charles Nicolle Hosp, Gastroenterol Dept, Tunis 1006, Tunisia

[2] Salah Azaiez Inst, Histopathol Dept, Tunis 1007, Tunisia

[3] El Amen Private Hosp, Radiol Dept, Nabeul 8000, Tunisia

[4] El Amen Private Hosp, Gastroenterol Dept, Nabeul 8000, Tunisia

来源：

FUTURE SCIENCE OA | 2023年

关键词：

anti-TNF therapy; Crohn's disease; diffuse large -B cell lymphoma; primary hepatic lymphoma; thiopurine;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Primary hepatic lymphoma is a rare variant of non-Hodgkin's lymphoma with an incidence of 0.016% of all non-Hodgkin lymphomas. The most common histologic subtype is large diffuse B-cell lymphoma. Pathogenesis is not clearly established and undergoing immunosuppressive therapy has been proposed as a risk factor for primary hepatic lymphoma. We report an intriguing case study, featuring a 23-year-old male patient with Crohn's Disease who had been receiving a combination therapy of thiopurine and anti-TNF for 6 years and was diagnosed with primary hepatic diffuse large B-cell lymphoma.

引用

页数：7

共 50 条

[41] Every fourth patient with Crohn's disease has anti-TNF dependency
Molnar, T.
Farkas, K.
Nyari, T.
Nagy, F.
Szepes, Z.
Wittmann, T.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 400 - U172
[42] Renal Cell Carcinoma in Fistulizing Crohn's Disease Patient Who Received Anti-TNF α Therapy
Albishi, Abdullah Mohammed
Chakik, Rafaat
Bazeed, Mohammed
CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2021, 2021
[43] Asymptomatic Parasitic Infection in a Crohn's Disease Patient on Anti-TNFα Therapy: An Alert for Our Patients?
Cocca, S.
Guarino, M.
Cicala, M.
JOURNAL OF CROHNS & COLITIS, 2016, 10 (12): : 1455 - 1456
[44] Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFα) therapy
Salavert, Miguel
Bastida, Guillermo
Peman, Javier
Nos, Pilar
REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (03): : 213 - 217
[45] Anti-TNF & alpha; induced lupus due to infliximab therapy in a patient with concurrent Crohn's disease
Sharma, Akanksha
Ahmed, Taha
Mehta, Aashna
Birnbaum, Julius
Shrestha, Abhigan Babu
CLINICAL CASE REPORTS, 2023, 11 (07):
[46] Nearly Fatal Case of Whipple's Disease in a Patient Mistakenly on Anti-TNF Therapy
Klochan, Christen
Anderson, Teresa A.
Rose, Dusten
Dimitrov, Rosen K.
Johnson, Raymond M.
ACG CASE REPORTS JOURNAL, 2013, 1 (01): : 25 - 28
[47] Interstitial lung disease occurring under anti-TNFα therapy for Crohn's disease
Rkiouak, A.
Reggad, A.
Akhouad, Y.
Kasmy, Z.
Boudlal, M.
Nait Lho, A.
Rabhi, M.
Radouane, B.
Ennibi, K.
Chaari, J.
REVUE FRANCAISE D ALLERGOLOGIE, 2014, 54 (07): : 500 - 504
[48] Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?
Magro, Fernando
Coelho, Rosa
Guimaraes, Luis S.
Silva, Marco
Peixoto, Armando
Lopes, Susana
Macedo, Guilherme
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 511 - 512
[49] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
Chen, Nai-Yu
Chiu, Yung-Ting
Chuang, Chiao-Hsiung
Chang, Yu-Ching
Cheng, Ching-Lan
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
[50] Fistula Healing in Perianal Crohn's Disease - With or Without Anti-TNF Therapy?
Yassin, N. A.
Askari, A.
Ferrari, L.
Faiz, O.
Warusavitarne, J.
Phillips, R.
Hart, A.
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S273 - S274

← 1 2 3 4 5 →